187 related articles for article (PubMed ID: 15621902)
21. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin.
Fuji T; Ochi T; Niwa S; Fujita S
J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459
[TBL] [Abstract][Full Text] [Related]
22. Dabigatran: new drug. Continue to use heparin, a better-known option.
Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
[TBL] [Abstract][Full Text] [Related]
23. Enoxaparin versus No Anticoagulation Prophylaxis after Total Knee Arthroplasty in Thai Patients: A Randomized Controlled Trial.
Intiyanaravut T; Thongpulsawasdi N; Sinthuvanich N; Teavirat S; Kunopart M
J Med Assoc Thai; 2017 Jan; 100(1):42-9. PubMed ID: 29911379
[TBL] [Abstract][Full Text] [Related]
24. Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators.
Hull RD; Pineo GF; Francis C; Bergqvist D; Fellenius C; Soderberg K; Holmqvist A; Mant M; Dear R; Baylis B; Mah A; Brant R
Arch Intern Med; 2000 Jul; 160(14):2208-15. PubMed ID: 10904465
[TBL] [Abstract][Full Text] [Related]
25. [Venous thromboembolism prophylaxis after total hip arthroplasty].
Kučera T; Malý R; Urban K; Sponer P
Acta Chir Orthop Traumatol Cech; 2011; 78(2):101-5. PubMed ID: 21575551
[TBL] [Abstract][Full Text] [Related]
26. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.
Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlundh U; Nicolas S; Nilsson P; Nylander G
N Engl J Med; 1996 Sep; 335(10):696-700. PubMed ID: 8703168
[TBL] [Abstract][Full Text] [Related]
27. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ;
Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
[TBL] [Abstract][Full Text] [Related]
28. Late deep venous thrombosis and delayed weightbearing after total hip arthroplasty.
Buehler KO; D'Lima DD; Petersilge WJ; Colwell CW; Walker RH
Clin Orthop Relat Res; 1999 Apr; (361):123-30. PubMed ID: 10212605
[TBL] [Abstract][Full Text] [Related]
29. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG;
N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the safety and efficacy of enoxaparin and warfarin for prevention of deep vein thrombosis after total knee arthroplasty.
Stern SH; Wixson RL; O'Connor D
J Arthroplasty; 2000 Feb; 15(2):153-8. PubMed ID: 10708078
[TBL] [Abstract][Full Text] [Related]
31. The incidence of deep vein thrombosis after hip and knee arthroplasties in Japanese patients: a prospective study.
Sudo A; Sano T; Horikawa K; Yamakawa T; Shi D; Uchida A
J Orthop Surg (Hong Kong); 2003 Dec; 11(2):174-7. PubMed ID: 14676343
[TBL] [Abstract][Full Text] [Related]
32. Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
Fisher WD; Eriksson BI; Bauer KA; Borris L; Dahl OE; Gent M; Haas S; Homering M; Huisman MV; Kakkar AK; Kälebo P; Kwong LM; Misselwitz F; Turpie AG
Thromb Haemost; 2007 Jun; 97(6):931-7. PubMed ID: 17549294
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery.
Menzin J; Colditz GA; Regan MM; Richner RE; Oster G
Arch Intern Med; 1995 Apr; 155(7):757-64. PubMed ID: 7695464
[TBL] [Abstract][Full Text] [Related]
34. An analysis of deep vein thrombosis in burn patients (part II): A randomized and controlled study of thrombo-prophylaxis with low molecular weight heparin.
Ahuja RB; Bansal P; Pradhan GS; Subberwal M
Burns; 2016 Dec; 42(8):1693-1698. PubMed ID: 27633687
[TBL] [Abstract][Full Text] [Related]
35. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].
Yang G; Lu H; Gao J; Kou B; Yuan Y; Xu B
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980
[TBL] [Abstract][Full Text] [Related]
36. [Thromboprophylaxis with enoxaparin for total knee replacement: an observational, retrospective and multicentre study comparing starting the treatment before and after the operation].
Llau JV; Gil-Garay E; Castellet E;
Rev Esp Anestesiol Reanim; 2012; 59(6):306-14. PubMed ID: 22738999
[TBL] [Abstract][Full Text] [Related]
37. Rates of proximal deep vein thrombosis as assessed by compression ultrasonography in patients receiving prolonged thromboprophylaxis with low molecular weight heparin after major orthopedic surgery.
Schellong S; Hesselschwerdt HJ; Paar WD; von Hanstein KL
Thromb Haemost; 2005 Sep; 94(3):532-6. PubMed ID: 16268468
[TBL] [Abstract][Full Text] [Related]
38. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.
Turpie AG; Gallus AS; Hoek JA;
N Engl J Med; 2001 Mar; 344(9):619-25. PubMed ID: 11228275
[TBL] [Abstract][Full Text] [Related]
39. Deep vein thrombosis after total hip and knee arthroplasty in Indian patients.
Jain V; Dhaon BK; Jaiswal A; Nigam V; Singla J
Postgrad Med J; 2004 Dec; 80(950):729-31. PubMed ID: 15579615
[TBL] [Abstract][Full Text] [Related]
40. A comparison of discharge and two-week duplex ultrasound screening protocols for deep venous thrombosis detection following primary total joint arthroplasty.
Dhupar S; Iorio R; Healy WL; Dhimitri K
J Bone Joint Surg Am; 2006 Nov; 88(11):2380-5. PubMed ID: 17079394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
